Seamaty Chengdu Future Medical Manufacturing Base Project Commences after 10 Years of Preparation

release time:2023-04-06 08:39:08

——Seamaty Chengdu Future Medical Manufacturing Base Project



At 9:00 a.m. on March 30th, amidst a warm and sunny spring morning, the opening ceremony of the POCT (Point-of-care testing) instrument and reagent manufacturing base project for Seamaty Technology Co., Ltd. was held in the Future Medical City of Chengdu East New District. Over 100 attendees, including Mr. Ran Peng, Chairman of Seamaty, representatives of Chengdu East New Area, project construction units, and distinguished guests from various industries, attended the event.

seamaty chairman having a speech about the grandopening of Seamaty Chengdu Future Medical Manufacturing Base Project

Speech by Mr. Ran Peng, Chairman of Seamaty

In his speech, Mr. Ran Peng stated that the commencement of this project marks a new milestone for Seamaty development, as the company enters the fast lane of rapid growth. After nearly 10 years of hard work, Seamaty is proud to stand at the forefront of the POCT field. The company will continue to expand this advantage, establish both high-quality products and channels, accelerate Seamaty brand building, make efforts to explore international and domestic markets, enhance Seamaty global influence, and achieve the company's second decade goals. The Chengdu Future Medical City, located in the core area of the Chengdu-Chongqing economic circle, boasts magnificent planning, beautiful environment, and considerate services, which is a dreamy place for Seamaty people and also a new starting point for Seamaty to look around the world in the POCT field.

The representatives of Chengdu East New Area stated that the Seamaty POCT Instrument And Reagent Manufacturing Base Project is the first social investment industrialization project with self-owned land in the Chengdu Future Medical City. After its completion, the project will become the largest production base in the central and western regions for POCT biochemical, immune, molecular diagnosis, blood gas electrolytes, and other instruments and supporting reagents, effectively promoting Chengdu in the POCT field from "following" to "leading"!

With the attendees' envisioning of Seamaty bright future, Chairman Ran Peng announced the official commencement of the Seamaty Chengdu Future Medical City POCT Instrument and Reagent Manufacturing Base Project. Representatives from Chengdu East New District, the company, the supervisory unit, the construction unit, the design unit, and Seamaty partners jointly planted the foundation for the project.

Seamaty partners jointly planted the foundation for the project

Ground-breaking

Group photo of some guests for Seamaty Chengdu Future Medical Manufacturing Base Project

Group photo of some guests


Projects Introduction

Seamaty Chengdu Future Medical Manufacturing Base Project rendering

Project rendering


The project is located in the Future Medical City on the shore of Sanji Lake in the East New District of Chengdu, east of Tianfu International Airport and north of Olympic Sports Park, which is the leading location of Chengdu-Chongqing twin-city economic circle. The project covers an area of 82 acres with a planned total construction area of 130,000 square meters, including technical R&D building, instrument and reagent production workshops, canteen, dormitory and other buildings. It is expected to be completed and put into operation one after another from 2024 to 2026. The new Seamaty base will mass produce POCT biochemical, immunological, blood gas electrolyte and molecular diagnostic instruments and reagent products after completion.

About Seamaty

Chengdu Seamaty Technology Co., Ltd. was established in 2012, and is a high-tech enterprise dedicated to the integration of R&D, production and sales of in vitro diagnostic POCT (instant test) products. The company has passed the German Rheinland ISO 13485:2016 quality management system certification, and obtained a number of CFDA medical device product registration certificates and medical device CE certification. After years of development, the company has built four major POCT technology platforms: biochemical analysis, blood gas electrolyte, capillary luminescence immunoassay and molecular diagnosis. We have set up overseas sales subsidiaries in Germany, Brazil, Russia, Turkey, Thailand, Singapore, Egypt and other countries to actively lay out the global market. Since the birth of the company, Seamaty has always adhered to the corporate mission of "care for life and health all over the world", with innovation, practicality and high cost performance as the purpose, the pursuit of excellence in product stability as the goal, and customer first as the company's development philosophy, firmly implement the international brand strategy, Gradually enhance Seamaty international and domestic influence.

After ten years of ingenious precipitation, Seamaty has developed to nearly 500 employees and the scale of more than 110 R&D technicians. In recent years, the average growth rate of company sales revenue has exceeded 50%. It is believed that Seamaty future will be even more brilliant after joining the Future Medical City of Chengdu East New District.


Prev Return Next

Related Reading

We Are Hiring Country Managers for South and West Africa Subsidiaries | Seamaty

2023-08-16

Seamaty is hiring country managers for South and West Africa subsidiaries.

Seamaty Chengdu Future Medical Manufacturing Base Project Commences after 10 Years of Preparation

2023-04-06

Seamaty Chengdu Future Medical Manufacturing Base Project has a grand opening on March 30, 2023.

Seamaty European subsidiaries | We Are Hiring!

2022-06-22

At present, to further expand the overseas market, we plan to set up subsidiaries and sales team in South America, such as Mexico, Brazil and other places, sincerely recruit the general manager, administrative and financial managers of the above companies.